For Business
Co-operation with our researchers gives the company a competitive advantage and access to world-class development services.
News
Medical researchers of the University of Tartu and doctors of Tartu University Hospital have an ambitious plan to take their novel combination of stereotactic body radiotherapy and immunotherapy to treatment guidelines and thus reach suitable patients suffering from lung cancer. Up to 20 lung cancer patients will be included in the study SynAct Lung to assess the safety and efficiency of the new combination.
Balbiino has introduced a new apricot-honey yoghurt ice cream with probiotic ME-3 bacteria discovered by medical researchers from the University of Tartu. Read More
ME-3, or the probiotic lactic acid bacterium Lactobacillus fermentum, has formed part of the Estonian diet for 17 years as an ingredient in Hellus dairy products, and has also been available as a food supplement since 2014. Now these highly beneficial bacteria have found their way into chocolate, in a new product launched in March by the internationally renowned Estonian chocolate artisans Chocolala in cooperation with researchers from the University of Tartu.
Read More
On 28 January the University of Tartu and Bolt presented the test car procured for the University of Tartu’s autonomous driving lab. This high-technology vehicle will be used for experiments in several research and development fields. The aim is to conduct test runs in urban traffic this year already. Read More